PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study, page-79

  1. 564 Posts.
    lightbulb Created with Sketch. 182
    it's more they're bringing the price down to profit off there short positions, or decrease the loss.

    Instead of holding onto short positions as the price goes upward.

    As we speak buyers strengthening!
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.